Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Invivyd (IVVD) Depreciation and Depletion (2021 - 2024)

Invivyd posted quarterly Depreciation and Depletion of $132000.0 for Q3 2024, up 10.92% year-on-year from $119000.0 in Q4 2023, and up 3.12% on a QoQ basis from $128000.0 in Q2 2024.

Invivyd (IVVD) has 4 years of Depreciation and Depletion data on file, last reported at $132000.0 in Q3 2024.

  • For the quarter ending Q3 2024, Depreciation and Depletion rose 10.92% year-over-year to $132000.0; the trailing twelve-month figure through Sep 2024 stood at $502000.0 (up 29.72% YoY), and the FY2023 full-year result was $480000.0, up 1070.73% from the prior year.
  • Depreciation and Depletion for Q3 2024 stood at $132000.0, up from $128000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $132000.0 in Q3 2024 and bottomed at $1000.0 in Q4 2021.
  • The 4-year median for Depreciation and Depletion is $119500.0 (2023), against an average of $75333.3.
  • The widest annual swing landed in 2023, when Depreciation and Depletion soared 2900.0%; it then gained 1.67% in 2024.
  • A 4-year view of Depreciation and Depletion shows it stood at $1000.0 in 2021, then soared by 2600.0% to $27000.0 in 2022, then soared by 344.44% to $120000.0 in 2023, then grew by 10.0% to $132000.0 in 2024.
  • The last three Depreciation and Depletion figures came in at $132000.0 (Q3 2024), $128000.0 (Q2 2024), and $122000.0 (Q1 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1,395.22
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Invivyd 208.38 Mn -18.31 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2024 132,000.00
Sep 30, 2024 132,000.00
Jun 30, 2024 128,000.00
Jun 30, 2024 128,000.00
Mar 31, 2024 122,000.00
Mar 31, 2024 122,000.00
Dec 31, 2023 120,000.00
Dec 31, 2023 120,000.00
Sep 30, 2023 119,000.00
Sep 30, 2023 119,000.00
Jun 30, 2023 121,000.00
Jun 30, 2023 121,000.00
Mar 31, 2023 120,000.00
Mar 31, 2023 120,000.00
Dec 31, 2022 27,000.00
Dec 31, 2022 27,000.00
Sep 30, 2022 5,000.00
Sep 30, 2022 5,000.00
Jun 30, 2022 5,000.00
Jun 30, 2022 5,000.00
Mar 31, 2022 4,000.00
Mar 31, 2022 4,000.00
Dec 31, 2021 1,000.00
Dec 31, 2021 1,000.00